cefuroxime has been researched along with Mast Cell Activation Disease in 1 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mastocytosis is a heterogeneous group of diseases characterized by excessive proliferation and accumulation of mast cells--in one or more organs." | 1.42 | [Anaphylaxis as part of a clinical diagnosis of mastocytosi - case demonstration]. ( Czarnobilska, E; Sacha, M; Stobiecki, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stobiecki, M | 1 |
| Sacha, M | 1 |
| Czarnobilska, E | 1 |
1 other study available for cefuroxime and Mast Cell Activation Disease
| Article | Year |
|---|---|
[Anaphylaxis as part of a clinical diagnosis of mastocytosi - case demonstration].
Topics: Adult; Anaphylaxis; Anti-Inflammatory Agents, Non-Steroidal; Cefuroxime; Drug Hypersensitivity; Fema | 2015 |